Biotech Values

[jaybird249]

CXM $1.03 + $.22 FDA approved drug

CXM could next STXS IMO, only 6 MM shares OS

No other biotech I know with an FDA approved product trades for less than $50 MM market cap.

Tons of other catalysts too, expanded distrbution of Exalgen, Insurance coverage, FDA application for improved Exalgen.

Don't get me wrong, its no blue chip, but in this biotech market, this could go much higher.